{"cdcTestId":"2013-0399","testcaseName":"#1 @ 11 yrs - 0 days, male, gardasil ","vaccineGroup":"HPV","evaluationTestType":"Age: At Recommended","forecastTestType":"Recommended based on interval","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2011-10-19T00:00:00","gender":"M"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"HPV9","cvx":"165","mvx":"","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"2","earliestDate":"2023-03-19T00:00:00","recommendedDate":"2023-04-19T00:00:00","pastDueDate":"2023-12-16T00:00:00"},"doses":[{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"HPV9","cvx":"165","mvx":"","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2018-02-13T13:25:40.116","generalDescription":"This test case describes when the first dose is administered at age 11 years - 0 days that the second dose of the HPV 2 dose series should be forecasted.","changedInVersion":"3.2","reasonForChange":"Updated to reflect current ACIP Recommendations for the 2 dose HPV vaccine."}